Héctor García-Calderó

发表

Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

B. Lavina, J. Bosch, A. Rodríguez-Vilarrupla, 2011, Journal of hepatology.

PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats.

B. Lavina, J. Bosch, L. Russo, 2012, Journal of hepatology.

The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

M. Avila, M. Ávila, J. Bosch, 2017, Hepatology.

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism

A. Spada, J. Bosch, Zoe Boyer-Diaz, 2019, Hepatology communications.

Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.

J. Bosch, B. Lavina, A. Rodríguez-Vilarrupla, 2007, Journal of hepatology.

Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice

S. Friedman, M. Coll, V. Hernández-Gea, 2021, Nutrients.

Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver

G. Garcı́a-Cardeña, L. Russo, J. Gracia-Sancho, 2010, Gut.

Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

J. Bosch, M. Ávila, J. García‐Pagán, 2016, Journal of hepatology.

BASIC AND TRANSLATIONAL — LIVER Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension

J. Bosch, J. García‐Pagán, J. Gracia‐Sancho, 2022 .

The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2022, Life.

Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2021, Scientific Reports.

Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats

G. Pietrosi, J. Bosch, J. Lozano, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Simvastatin maintains function and viability of steatotic rat livers procured for transplantation.

J. Bosch, C. Peralta, J. García‐Pagán, 2013, Journal of hepatology.

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD

J. Bosch, J. García‐Pagán, J. Abraldes, 2012, PloS one.

Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers

G. Garcı́a-Cardeña, J. Bosch, J. García‐Pagán, 2012, Hepatology.

Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End

Regina Elena, D. Féliers, G. Schett, 2016 .

Terutroban, a TP‐receptor antagonist, reduces portal pressure in cirrhotic rats

J. García‐Pagán, J. Bosch, A. Rodríguez-Vilarrupla, 2013, Hepatology.

Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability

Mercedes Fernandez, B. Lavina, J. Bosch, 2007, Hepatology.

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.

J. Bosch, M. Graupera, J. García‐Pagán, 2007, Journal of hepatology.

Mitochondria-targeted antioxidant mitoquinone deactivates human and rat HSC and reduces portal hypertension in cirrhotic rats

M. Murphy, R. Deulofeu, J. García‐Pagán, 2017 .

Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.

S. Sarin, J. Bosch, J. García‐Pagán, 2015, American journal of physiology. Gastrointestinal and liver physiology.

Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.

J. Bosch, J. García‐Pagán, J. Gracia‐Sancho, 2018, Gastroenterology.

Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.

J. Bosch, Mercedes Fernandez, R. Deulofeu, 2008, Journal of hepatology.

Rivaroxaban Reduces Portal Hypertension in Cirrhotic Rats by Deactivating Hepatic Stellate Cells and Reducing Intrahepatic Microthrombosis

M. Ávila, J. García‐Pagán, J. Bosch, 2016 .

Simvastatin Attenuates Liver Injury in Rodents with Biliary Cirrhosis Submitted to Hemorrhage/Resuscitation

J. Bosch, J. Lozano, J. García‐Pagán, 2017, Shock.

Mitochondria‐targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats

M. Murphy, R. Deulofeu, J. García‐Pagán, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.

S. Sarin, J. Bosch, J. García‐Pagán, 2015, American journal of physiology. Gastrointestinal and liver physiology.

Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability

Mercedes Fernandez, B. Lavina, J. Bosch, 2007, Hepatology.

Lack of endothelial autophagy does not impair liver regeneration after partial hepatectomy in mice

V. Hernández-Gea, Maria Ruart, J. García-Pagán, 2023, Liver international : official journal of the International Association for the Study of the Liver.